Natural killer cell immunotypes related to COVID-19 disease severity
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The NK cell activation landscape in acute SARS-CoV-2 infection is associated with COVID-19 disease severity.
Article activity feed
-
-
SciScore for 10.1101/2020.07.07.20148478: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: The study was approved by the Swedish Ethical Review Authority and all patients gave informed consent. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Healthy controls were SARS-CoV-2 IgG seronegative at time of inclusion, median age was 50-59 years, and 11 out of 17 were male (65%). Table 2: Resources
Software and Algorithms Sentences Resources Flow cytometry data analysis: FCS3.0 files were exported from the FACSDiva and imported into FlowJo v. FACSDivasuggested: (BD FACSDiva Software, RRID:SCR_001456)FlowJosuggested: (FlowJo, RRID:SCR_008520)Certain figures were generated in R (versions 3.6.0 and … SciScore for 10.1101/2020.07.07.20148478: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: The study was approved by the Swedish Ethical Review Authority and all patients gave informed consent. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Healthy controls were SARS-CoV-2 IgG seronegative at time of inclusion, median age was 50-59 years, and 11 out of 17 were male (65%). Table 2: Resources
Software and Algorithms Sentences Resources Flow cytometry data analysis: FCS3.0 files were exported from the FACSDiva and imported into FlowJo v. FACSDivasuggested: (BD FACSDiva Software, RRID:SCR_001456)FlowJosuggested: (FlowJo, RRID:SCR_008520)Certain figures were generated in R (versions 3.6.0 and 3.6.1) with packages factoextra (v1.0.5), RColorBrewer (v1.1-2), ggplot2 (v3.2.1 and v3.3.0), tidyr (v.1.0.2), randomcoloR (v.1.1.0.1), reshape2 (v.1.4.3), viridis (v.0.5.1), and pheatmap (v.10.12). pheatmapsuggested: (pheatmap, RRID:SCR_016418)Data in h5 format was read using Seurat (v3.1.5) then filtered for zero-variance genes and size-factor normalized using scater v1.12.2/scran v1.12.1. scatersuggested: (scater, RRID:SCR_015954)Pairwise differential expression of genes detected in at least 20% of cells was performed using MAST (v1.10.0) and genes with an FDR < 10−3 in any comparison were clustered into six clusters (determined by gap statistic) by k-means clustering of Z-scores. MASTsuggested: (MAST, RRID:SCR_016340)Gene ontology enrichment of gene clusters was performed using PANTHER overrepresentation tests (release 20200407) using gene ontology database 2020-03-23. PANTHERsuggested: (PANTHER, RRID:SCR_004869)Data was visualized using ComplexHeatmap (v2.0.0) and ggplot2 (v3.2.1). ComplexHeatmapsuggested: (ComplexHeatmap, RRID:SCR_017270)ggplot2suggested: (ggplot2, RRID:SCR_014601)Statistical analysis: Data was analyzed in GraphPad Prism v8. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Significant PhenoGraph clusters (P ≤ 0.05) were determined by Chi-Square goodness-of-fit tests comparing the relative abundance of each categorical group in each individual PhenoGraph cluster relative to input. PhenoGraphsuggested: (Phenograph, RRID:SCR_016919)Supplementary Figure 1: NK cell differentiation in COVID-19 disease Supplementary Figure 2: NK cell activation in COVID-19 disease Supplementary Figure 3: KIRs and NK cell education in COVID-19 disease Supplementary Figure 4: Adaptive NK cell expansions in COVID-19 Supplementary Figure 5: Strategy for UMAP analysis and representative marker expression Supplementary Figure 6: Selected PhenoGraph clusters and their markers are expressed differentially across clinical parameter-defined patient groups Supplementary Figure 7: Correlations between CD56bright NK cell arming, NK cell phenotype, and soluble factors in COVID-19 Supplementary Table 1: Clinical characteristics of Covid-19 patients Supplementary Table 2: Clinical laboratory results of Covid-19 patients Supplementary Table 3: Flow cytometry panel Supplementary Table 4: Gene ontology analysis of DEGs from scRNAseq analysis of BAL NK cells in COVID-19 Supplementary Table 5: KIR-ligand typing of the study cohort Supplementary Table 6A: Clinical laboratory results of all patients with and without adaptive NK cell expansions Supplementary Table 6B: Clinical laboratory results of severe patients with and without adaptive NK cell expansions Supplementary Table 7: Analysis of the observed distribution of PhenoGraph clusters across clinical parameter-defined groups Supplementary Table 8A: Literature-curated interactions from International Molecular Exchange Consortium (IMEx) interactom database Supplementary Table 8B: Nodes and related degrees and betweenness Supplementary Table 8C: Overview of the KEGG pathways KEGGsuggested: (KEGG, RRID:SCR_012773)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-